Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

X
Drug Profile

Ibuprofen - Oxford Pharmascience

Alternative Names: Ibuprofen oral suspension - Oxford Pharmascience; Ibuprofen-layered double hydroxide; Ibuprofen-LDH; OXP 001; OXP 002; OXProfen; OXPzero™ Ibuprofen;See more

Latest Information Update: 07 Jan 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oxford Pharmascience
  • Class Amines; Analgesics; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Musculoskeletal pain

Most Recent Events

  • 28 Nov 2021 No recent reports of development identified for phase-I development in Musculoskeletal-pain in United Kingdom (PO, Tablet)
  • 27 Feb 2018 Ibuprofen is still in phase I trials for Musculoskeletal pain in UK
  • 27 Sep 2017 Suspended - Phase-I for Musculoskeletal pain in United Kingdom, pending conclusion of a strategic review (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days